Charles Makin

Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

Niklas Bergvall, Allison Petrilla, Swapna Karkare et al. · Journal of Medical Economics · 2014 · 91 citations

Pharmacy, Neurology, Pharmacotherapy +15

Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study

Niklas Bergvall, Charles Makin, Raquel Lahoz et al. · PLoS ONE · 2014 · 70 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA

Alberto Ferreira, Alexandros Sagkriotis, Melvin Olson et al. · PLoS ONE · 2015 · 57 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis

Niklas Bergvall, Charles Makin, Raquel Lahoz et al. · Current Medical Research and Opinion · 2013 · 40 citations

Pharmacy, Neurology, Pharmacotherapy +13

Work and productivity loss related to herpes zoster

Puneet K. Singhal, Charles Makin, James M. Pellissier et al. · Journal of Medical Economics · 2011 · 32 citations · Full text

Public Health, Health Sciences, Behavioral Epidemiology +15